Israel Englander’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,200
Closed -$173K 5800
2024
Q4
$173K Buy
+18,200
New +$184K ﹤0.01% 5349
2024
Q3
Sell
-100,300
Closed -$1M 6048
2024
Q2
$1M Buy
+100,300
New +$1.02M ﹤0.01% 4109
2023
Q2
Sell
-30,600
Closed -$380K 6058
2023
Q1
$380K Sell
30,600
-19,700
-39% -$362K ﹤0.01% 4757
2022
Q4
$967K Buy
+50,300
New +$1.06M ﹤0.01% 4199

Other funds holding AHCO

Israel Englander's AHCO Position: Q2 2026 in Review

Israel Englander reduced its AdaptHealth (AHCO) stake by 47% in Q2 2026, selling an estimated $3.5M and leaving 347,920 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3308.

Israel Englander first reported a position in AHCO in Q4 2019 and has held it in 25 quarters since. The position peaked at $36.1M in Q3 2024. 237 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Israel Englander held 347,920 shares of AdaptHealth worth $3.63M as of Q2 2026.
  • Israel Englander sold 313,300 AdaptHealth shares in Q2 2026, an estimated $3.5M.
  • AdaptHealth made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3308 holding.
  • Israel Englander first reported a position in AdaptHealth in Q4 2019 and has held it in 25 quarters since.
  • Israel Englander's AdaptHealth position peaked at $36.1M in Q3 2024.
  • 237 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.